Skip to content
Business Segments · Research and development expenses

Analytical Instruments — Research and development expenses

Thermo Fisher Scientific Analytical Instruments — Research and development expenses decreased by 5.4% to $139M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.5%, from $137M to $139M. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ1 2023
Last reportedQ1 2026May 1, 2026
Rolls up toR&D

How to read this metric

Consistent or increasing investment is generally positive for long-term growth, whereas significant cuts may signal a focus on short-term profitability at the expense of innovation.

Detailed definition

Investments made by the Analytical Instruments segment into the discovery and development of new scientific technologies...

Peer comparison

A critical metric for comparing innovation intensity among life science and instrumentation peers.

Metric ID: tmo_segment_analytical_instruments_research_and_development_expenses

Historical Data

11 periods
 Q1 '23Q2 '23Q3 '23Q4 '23Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$132M$132M$132M$132M$134M$146M$137M$145M$144M$147M$139M
QoQ Change+0.0%+0.0%+0.0%+1.5%+9.0%-6.2%+5.8%-0.7%+2.1%-5.4%
YoY Change+1.5%+10.6%+7.5%+0.7%+1.5%
Range$132M$147M
CAGR+2.1%
Avg YoY Growth+4.3%
Median YoY Growth+1.5%

Frequently Asked Questions

What is Thermo Fisher Scientific's analytical instruments — research and development expenses?
Thermo Fisher Scientific (TMO) reported analytical instruments — research and development expenses of $139M in Q1 2026.
How has Thermo Fisher Scientific's analytical instruments — research and development expenses changed year-over-year?
Thermo Fisher Scientific's analytical instruments — research and development expenses increased by 1.5% year-over-year, from $137M to $139M.
What does analytical instruments — research and development expenses mean?
Spending on innovation and new product development for the segment.